About Spatial Transcriptomics
Spatial Transcriptomics is a Healthcare company based in Solna (Sweden) founded in 2013, and was acquired by 10X Genomics in December 2018. Tools for gene expression visualization in tissue samples are provided. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics.
Company details
Spatial Transcriptomics was founded in 2013 in Solna, Sweden, and operates in the biotechnology sector focused on spatial transcriptomics. Proprietary tools are offered for visualizing gene expression data from FFPE samples using microchip arrays. Structural information is captured through imaging and next-generation sequencing algorithms. Researchers are enabled to analyze gene expression levels across tissue sections alongside cell morphological details.
- Headquarters Solna, Sweden
- Stage Acquired
- SectorsHealthcare
- Website spatialtranscriptomics.com
- Social LinkedIn YouTube
- Acquired by 10X Genomics (Dec 2018)
- Investors
- Acquired by10X Genomics
(Dec 2018)
Apps and channels of Spatial Transcriptomics
its YouTube channel 10x Genomics has 6.98K subscribers and 30 videos.
Videos from Spatial Transcriptomics
The most watched videos on Spatial Transcriptomics's YouTube channel, 10x Genomics (6.98K subscribers). Click a video to play it here.
More on 10x Genomics.
Investors in Spatial Transcriptomics
Spatial Transcriptomics has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Instrument systems for genomic research and sequencing libraries are developed. | 2012 | 10xgenomics.com | Pleasanton, United States |
Investor details for Spatial Transcriptomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Spatial Transcriptomics
2 dated milestones of Spatial Transcriptomics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Spatial Transcriptomics is founded.
- Exit Acquired by 10X Genomics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spatial Transcriptomics
Spatial Transcriptomics was founded in 2013.
Spatial Transcriptomics is headquartered in Solna, Sweden.
Spatial Transcriptomics was founded in 2013 in Solna, Sweden, and operates in the biotechnology sector focused on spatial transcriptomics. Proprietary tools are offered for visualizing gene expression data from FFPE samples using microchip arrays. Structural information is captured through imaging and next-generation sequencing algorithms. Researchers are enabled to analyze gene expression levels across tissue sections alongside cell morphological details.
Spatial Transcriptomics has 1 investor. Key investors include 10X Genomics.
Yes. Spatial Transcriptomics was acquired by 10X Genomics in December 2018.
